State of New Jersey Common Pension Fund D Sells 7,384 Shares of HCA Healthcare, Inc. $HCA

State of New Jersey Common Pension Fund D reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 56,217 shares of the company’s stock after selling 7,384 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in HCA Healthcare were worth $26,245,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Canandaigua National Bank & Trust Co. increased its stake in HCA Healthcare by 6.2% during the fourth quarter. Canandaigua National Bank & Trust Co. now owns 4,734 shares of the company’s stock worth $2,210,000 after acquiring an additional 276 shares during the last quarter. Turning Point Benefit Group Inc. increased its stake in HCA Healthcare by 1,740.0% during the fourth quarter. Turning Point Benefit Group Inc. now owns 92 shares of the company’s stock worth $43,000 after acquiring an additional 87 shares during the last quarter. Narwhal Capital Management boosted its position in shares of HCA Healthcare by 88.2% during the fourth quarter. Narwhal Capital Management now owns 13,243 shares of the company’s stock valued at $6,183,000 after buying an additional 6,205 shares during the period. Interchange Capital Partners LLC boosted its position in shares of HCA Healthcare by 8.1% during the fourth quarter. Interchange Capital Partners LLC now owns 4,733 shares of the company’s stock valued at $2,210,000 after buying an additional 353 shares during the period. Finally, Keybank National Association OH boosted its position in shares of HCA Healthcare by 2.8% during the fourth quarter. Keybank National Association OH now owns 3,627 shares of the company’s stock valued at $1,693,000 after buying an additional 100 shares during the period. 62.73% of the stock is owned by institutional investors.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA plans a major expansion at its Kendall (Miami‑Dade) hospital, signaling revenue/capacity growth in a key market and supporting longer‑term organic growth prospects. HCA Florida Kendall Hospital Plans Expansion
• Positive Sentiment: HCA will present at the RBC Global Healthcare Conference on May 20 — an opportunity to reinforce its FY2026 guidance (EPS range reiterated) and highlight execution plans to investors. Increased investor visibility can support multiple expansion or valuation reassessment. HCA Healthcare to Present at May Conference
• Neutral Sentiment: Quarterly results showed $19.1B in revenue (up ~4.3% y/y) but a slight EPS miss; management maintained FY26 EPS guidance. Revenue growth is encouraging but the EPS miss and operational headwinds (storm impacts, lower ER volumes) make this a mixed read for near‑term earnings momentum. HCA Posts $19.1B in Revenue
• Neutral Sentiment: Multiple local executive moves (COO hires/transfers in Missouri, California and a Florida CEO moving to Virginia) are routine for a large system and unlikely to move the stock materially, though they reflect ongoing operational re‑shuffles. HCA Missouri Hospital Taps New COO HCA Florida CEO Transitions CEO Responses to Lawmaker Comments
• Neutral Sentiment: Sector/idea pieces (e.g., Zacks highlighting medical stocks) may draw fresh buyer interest into healthcare names including HCA, but these are general flows rather than HCA‑specific catalysts. Zacks: Two Medical Stocks
• Negative Sentiment: Analyst action: a published target cut (Yahoo Finance coverage) pressures valuation and can weigh on sentiment, even if the firm still credits HCA’s operational execution. Investor reaction to lowered price targets can be downward. HCA: A Target Cut
• Negative Sentiment: HCA confirmed layoffs — a near‑term negative headline that may reflect margin pressure and restructuring; while cost cuts can help margins later, layoffs often create short‑term investor uncertainty. HCA Confirms Layoffs
• Negative Sentiment: Ongoing regulatory and public scrutiny (examples: lawmakers’ comments on hospital profitability and regional competition/appeals in local markets) could increase reputational or policy risk over time. AdventHealth/UNC Appeal Decision

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $435.01 on Friday. The company has a market capitalization of $96.78 billion, a PE ratio of 14.96, a P/E/G ratio of 1.38 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a 50 day moving average price of $497.66 and a 200-day moving average price of $485.41.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period last year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.73%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

HCA has been the subject of several recent analyst reports. TD Cowen dropped their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday. Barclays dropped their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday. Sanford C. Bernstein decreased their price target on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research note on Tuesday. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Finally, Robert W. Baird decreased their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $520.55.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.